Noncommunicable Diseases Clinical Trials
2 recruiting trials for Noncommunicable Diseases. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Noncommunicable Diseases clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by The University of Hong Kong (1), Gdansk University of Physical Education and Sport (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is COVID-19 outbreaks (other, 1 trial), followed by High intensity interval training program for pregnant women, Moderate intensity continuous training program for pregnant women.
Track Noncommunicable Diseases trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases
Objectives and aim: To evaluate the long-term spill-over (indirect) effect of Coronavirus disease (COVID-19) on health outcomes and healthcare utilization among people with...
HIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and Children
Regular exercise during pregnancy and postpartum leads to health benefits for mother and child. Inactivity during pregnancy and after delivery is now treated as risky behavior....
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Noncommunicable Diseases, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Noncommunicable Diseases, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Noncommunicable Diseases, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.